Specialty Products

Consilient Health is committed to licensing or developing products which provide added value for patients and the NHS. Examples of some of our products are shown below.


Emozul® (esomeprazole) 20mg & 40mg gastro-resistant Capsules 

Strength: 20mg PIL SPC
Strength: 40mg PIL SPC

Emozul® capsules provide esomeprazole 20mg or 40mg in a capsule formulation.

Emozul® is a trademark of Krka, d. d. and Nexium® is a trademark of AstraZeneca group of companies

Atorvastatin 30mg and 60mg Tablets

Strength: 30mg PIL SPC
Strength: 60mg PIL SPC

Atorvastatin is available from Consilient Health in two strengths of 30mg and 60mg.  



Laaglyda MR 60mg Tablets
Pack Laaglyda MR 60mg

Strength: 60mg PIL SPC

Laaglyda® (gliclazide) MR 60mg modified-release tablets is available from Consilient Health.

Laaglyda® is a trademark of KRKA.



 Perindopril + Amlodipine Tablets

Pack PerindoprilAmplodipine 8-10mg 

Strength: 8mg/10mg PIL SPC

Combination therapy of Perindopril/Amlodipine tablets.

Available as Perindopril/Amlodipine 8mg/10mg, 4mg/10mg, 8mg/5mg, 4mg/5mg.





Desmopressin 360 micrograms/ml Oral Solution



Rewisca® (pregabalin) 25mg, 50mg, 75mg, 100mg, 150mg, 200mg, 225mg and 300mg hard capsules 

Strength: 25mg PIL SPC
Strength: 50mg PIL SPC
Strength: 75mg PIL SPC
Strength: 100mg PIL SPC
Strength: 150mg PIL SPC
Strength: 200mg PIL SPC
Strength: 225mg PIL SPC
Strength: 300mg PIL SPC
Ordering information for Pharmacies


As of 1st November, prescription validation is no longer required to obtain Rewisca (pregabalin) hard capsules. You are now able to order Rewisca from either Alliance Healthcare (Distribution) Ltd and Phoenix Healthcare Distribution in the normal way, e.g. via your PMR; there is no need to submit a copy of the Rewisca prescription.

Purchases will not be subject to any surcharges if ordered in isolation. Any questions, contact the local customer service centre of your selected wholesaler.


Other new products & Business Development

A pipeline of new products are currently being developed will be launched over the course of the next year.

Consilient are constantly searching for products that will provide benefits for patients, prescribers and the NHS. External companies with products that maybe suitable should contact This email address is being protected from spambots. You need JavaScript enabled to view it.





CH-CORP-005-09/2015c   Date of preparation September 2015

Corporate Headquarters

Block 2A Richview Office Park
Clonskeagh, Dublin14

T. +353 (0)1 2057760
E. info@consilienthealth.com

UK Office

No1 Church Road
Richmond Upon Thames

T. +44 (0)20 3751 1888
F. +44 (0)20 3751 1889
E. info@consilienthealth.com

For Pharmacovigilance or Medical enquiries please email drugsafety@consilienthealth.com or ring 0203 751 1888.